» Articles » PMID: 38493433

The Impact of Pulmonary Hydatid Cyst Rupture on COVID-19 Symptom Severity

Overview
Journal Acta Parasitol
Specialty Parasitology
Date 2024 Mar 17
PMID 38493433
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Co-infection with other microorganisms such as parasites in patients with COVID-19 can affect the clinical outcome and require prompt diagnosis and appropriate therapy.

Case Presentation: We present a case of an adult male with chest pain, dyspnea, cough, diplopia, and anorexia who was confirmed to have acute COVID-19 pneumonia. 2 weeks prior to admission, a hydatid lung cyst was identified on examination, but the patient refused surgery. Thoracoabdominal computed tomography (CT) revealed a rupture of the lung hydatid cyst and co-infection with COVID-19. The patient has prescribed a treatment protocol for COVID-19 and albendazole. Despite measures taken to manage severe inflammation and decreasing blood oxygen levels, the patient required admission to the intensive care unit (ICU) and intubation. After approximately 3 weeks of hospitalization, the patient was successfully extubated and discharged uneventfully from the hospital. Oral albendazole was prescribed for follow-up treatment.

Conclusion: Our case highlights the importance of considering hydatid cysts in the differential diagnosis of patients with COVID-19, especially those living in endemic areas.

References
1.
Alemzadeh E, Alemzadeh E, Ziaee M, Abedi A, Salehiniya H . The effect of low serum calcium level on the severity and mortality of Covid patients: A systematic review and meta-analysis. Immun Inflamm Dis. 2021; 9(4):1219-1228. PMC: 8589360. DOI: 10.1002/iid3.528. View

2.
Sinha P, Matthay M, Calfee C . Is a "Cytokine Storm" Relevant to COVID-19?. JAMA Intern Med. 2020; 180(9):1152-1154. DOI: 10.1001/jamainternmed.2020.3313. View

3.
Pagheh A, Ziaee A, Abrari Romenjan K, Rezaei F, Bahman B, Alamzadeh E . SARS-COV-2 IgG specific antibodies persistence in recovered COVID-19 individuals and its association with severity and time of illness. New Microbes New Infect. 2023; 52:101096. PMC: 9896850. DOI: 10.1016/j.nmni.2023.101096. View

4.
Cepon-Robins T, Gildner T . Old friends meet a new foe: A potential role for immune-priming parasites in mitigating COVID-19 morbidity and mortality. Evol Med Public Health. 2020; 2020(1):234-248. PMC: 7665448. DOI: 10.1093/emph/eoaa037. View

5.
Eckert J, Deplazes P . Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern. Clin Microbiol Rev. 2004; 17(1):107-35. PMC: 321468. DOI: 10.1128/CMR.17.1.107-135.2004. View